Preventing infections acquired during hospital stays is one tool in the fight against antimicrobial resistance. The knowledge and technology to do so exists, is well proven and is cost effective in the long term, according to Swedish medical device company Bactiguard. The technology referred to is based on a very thin coating being applied to the...
Congratulations Martin Holmbom, Department of Urology and Department of Clinical and Experimental Medicine, Linköping University, who today was awarded Bactiguard’s scholarship of SEK 25.000 for the best abstract in the field of urological infections. Martin's research has identified risk factors clearly associated with mortality in...
This week we have welcomed delegates from Malaysia Investment and Development Agency (MIDA) in our office in Tullinge to discuss future development projects in the region. In accordance with our strategic direction to further expand our business in Malaysia and Southeast Asia, we recently inaugurated a new warehouse in Penang, Malaysia. This...
Every year at least 11 million deaths globally are caused by sepsis, which always starts with an infection. Sepsis is the number one preventable cause of death in world. To raise awareness about how to prevent and identify signs of sepsis, World Sepsis Days takes place. Sepsis is the number one preventable cause of death in the world, but very...
Infections related to orthopedic surgery is a common problem but can be prevented by using a technology developed by Bactiguard, former known as Vigilenz. A collaboration between University Kebangsaan in Malaysia and Bactiguard aims at making this technology more available to a larger group of patients worldwide. The Bactiguard technology is a...
Bactiguard South East Asia have now completed the expansion of the new warehouse building in the current facility, reflecting the need for the continuous expansion of the business growth. The total build-up area added will be 12,220sq ft in 2 storey building including warehouse, Microbiology lab, Product Development Lab, Operational and...
A new study has been published on Bactiguard’s endotracheal tube (BIP ETT) that shows a significant reduction of both ventilator-associated pneumonia (VAP) and antibiotic use. This randomized controlled study on 180 intensive care patients was published in the Balcan Medical Journal, in March 2022. The main objective of the study was to evaluate...
Antimicrobial resistance already causes millions of deaths according to the most comprehensive study on the burden of AMR so far, published in The Lancet. It shows that almost 1,3 million deaths were directly attributable to bacterial AMR in 2019 and almost 5 million deaths associated with AMR. This is evidence that the fight against antimicrobial...
